News. 01/10/01

Procuritas et al sell Ventilatorverken AB to A/S Dantherm Holding

Press Release

Investeringssällskapet AB 2 (“ISAB 2“) has sold Ventilatorverken AB to A/S Dantherm Holding. Ventilatorverken manufactures products for efficient air handling, and provides solutions within air treatment for industrial processes.

Ventilatorverken AB was part of ISAB 2, a holding company for former BPA non-core businesses. It was formed as the core installation business of Swedish BPA AB was merged with Norwegian Bravida AS. The ISAB 2 group consists of seven companies, the largest of which is Hallström & Nisses Fastighets AB.

ISAB 2 is owned by a consortium consisting of the buyout fund Procuritas Capital Partners II (PCP II), Finnish companies Sampo Liv Insurance Company and Sponsor Capital, Baring Private Equity Partners, and Swedish investment companies Latour and Atle.

Dantherm Holding is the parent company of a number of companies producing equipment and services for ventilation, dehumidification and heating.

More news.

09/04/24

Polarn O. Pyret appoints Sara Sjöberg as new CEO

Procuritas Capital Investors VI (”Procuritas”), the Swedish private equity firm dedicated to growing Nordic mid-market enterprises, is delighted to announce the appointment of Sara Sjöberg as the forthcoming Chief Executive Officer for its portfolio company, Polarn O. Pyret, the iconic Swedish childrenswear brand. Sara Sjöberg steps into this role with a wealth of experience from...

 08/04/24

Humana to acquire Team Olivia’s Norwegian operation

Team Olivia, a leading care service provider in the Nordics has entered into an agreement to sell its Norwegian operations, Team Olivia Norge AS, to Human Care Holding AS (“Humana”). The Transaction is subject to approval by the Norwegian competition authority and is expected to be completed during the second quarter of 2024. Team Olivia,...

 28/02/24

Procuritas partners up with Precision BioLogic

Procuritas Capital Investors VII (Procuritas) acquires Precision BioLogic (PBI) and subsidiary (Affinity Biologicals), fast-growing niche leaders in hemostasis diagnostics and research. PBI has in recent years launched a number of successful diagnostics products and is active in a growing market, supported by long-term trends such as ageing population, emerging new therapies, and increased access to...